Odactra Sub Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. When you're ready to take your dose, remove the medication from the blister pack and place it under your tongue, allowing it to dissolve completely. Do not chew, suck, or swallow the tablet. Wait at least 1 minute before swallowing after placing the medication in your mouth. Avoid eating or drinking while the tablet is dissolving or for 5 minutes after it has dissolved. After handling the medication, wash your hands thoroughly.
Storing and Disposing of Your Medication
Store your medication in its original container at room temperature in a dry location, avoiding bathrooms. Keep all medications in a safe place, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you're unsure about the best way to dispose of your medication, consult your pharmacist. You may also have access to drug take-back programs in your area.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or extra doses. If you miss 7 consecutive days of medication, contact your doctor for guidance on how to proceed.
Lifestyle & Tips
- Take the tablet immediately after removing it from the blister pack.
- Place the tablet under your tongue and allow it to dissolve completely (usually 10-20 seconds). Do not swallow for at least 1 minute.
- Do not eat or drink for at least 5 minutes after taking the tablet.
- Wash your hands after handling the tablet.
- Always carry two auto-injectable epinephrine devices (e.g., EpiPen) as instructed by your doctor, and know how to use them.
- Avoid taking Odactra if you have any cuts, sores, or inflammation in your mouth, as this may increase the risk of side effects. Wait until your mouth heals.
- Inform your doctor if you experience any severe allergic reactions or worsening asthma symptoms.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Some allergic reactions can be life-threatening
Trouble swallowing or speaking
Pain when swallowing
Heartburn
Chest pain or pressure
Fast heartbeat
Passing out
Dizziness
Flushing
Shortness of breath
Cough
Severe stomach upset or vomiting
Stomach cramps
Mouth irritation or mouth sores
Other Possible Side Effects
Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor:
Itching in the ear, mouth, or tongue
Throat pain
Throat irritation
Upset stomach
Stomach pain or diarrhea
* Change in taste
Reporting Side Effects
This list does not include all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Difficulty breathing or swallowing
- Wheezing or shortness of breath
- Dizziness or fainting
- Rapid or weak heartbeat
- Severe rash, hives, or itching
- Swelling of the face, lips, tongue, or throat
- Severe stomach pain, vomiting, or diarrhea
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
A history of severe allergic reactions.
A diagnosis of eosinophilic esophagitis.
Any current or recent mouth-related issues, including swelling, sores, infections, mouth injuries, tooth loss, or oral surgery.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Note that this drug is not effective in relieving allergy symptoms that have already appeared. If you are experiencing allergy symptoms, consult with your doctor to discuss the best course of action.
If you have asthma and experience difficulty breathing or notice that your asthma symptoms are worsening, contact your doctor immediately.
Before taking this medication, inform your doctor if you are pregnant, planning to become pregnant, or are breastfeeding. Your doctor will help you weigh the benefits and risks of using this medication to ensure the best possible outcome for you and your baby.
Overdose Information
Overdose Symptoms:
- Severe systemic allergic reactions (anaphylaxis)
- Exacerbation of asthma symptoms
- Severe local oral reactions
What to Do:
Seek immediate emergency medical attention. Administer auto-injectable epinephrine if available and indicated. Call 911 or your local emergency number. Call Poison Control at 1-800-222-1222.
Drug Interactions
Contraindicated Interactions
- Patients with severe, unstable, or uncontrolled asthma
- Patients with a history of severe systemic allergic reaction to allergen immunotherapy
- Patients with eosinophilic esophagitis
- Patients who are unable to comply with the administration instructions (e.g., unable to hold the tablet under the tongue for the required time)
Major Interactions
- Beta-blockers (may exacerbate anaphylaxis and reduce effectiveness of epinephrine)
- Monoamine Oxidase Inhibitors (MAOIs), Tricyclic Antidepressants (TCAs), and Catechol-O-Methyltransferase (COMT) inhibitors (may potentiate effects of epinephrine)
Moderate Interactions
- Antihistamines (may mask early symptoms of systemic allergic reactions)
- Corticosteroids (may reduce the immune response to the allergen extract, but generally not a contraindication for use)
Monitoring
Baseline Monitoring
Rationale: To ensure asthma is stable and well-controlled before initiating treatment, as uncontrolled asthma is a contraindication.
Timing: Prior to first dose
Rationale: To identify patients at higher risk for adverse events.
Timing: Prior to first dose
Rationale: To ensure no significant inflammation, wounds, or lesions that could increase systemic absorption and risk of adverse reactions.
Timing: Prior to first dose
Routine Monitoring
Frequency: Daily, especially during initial weeks
Target: Minimal to mild
Action Threshold: Persistent, severe, or worsening symptoms may require temporary discontinuation or re-evaluation.
Frequency: Daily, especially during initial weeks and with each dose
Target: Absence of symptoms
Action Threshold: Any systemic reaction requires immediate medical attention and evaluation for epinephrine administration.
Frequency: Regularly, as per asthma management guidelines
Target: Well-controlled
Action Threshold: Worsening or uncontrolled asthma requires immediate medical evaluation and potential discontinuation of Odactra.
Symptom Monitoring
- Oral itching
- Oral swelling
- Throat irritation
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Urticaria (hives)
- Angioedema (swelling of face, lips, tongue, throat)
- Dyspnea (shortness of breath)
- Wheezing
- Cough
- Chest tightness
- Dizziness
- Lightheadedness
- Fainting
- Rapid or weak pulse
- Hypotension (low blood pressure)
Special Patient Groups
Pregnancy
Limited data available. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. The FDA label states that available data are insufficient to inform a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.
Trimester-Specific Risks:
Lactation
No data on the presence of Odactra in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the motherβs clinical need for Odactra and any potential adverse effects on the breastfed infant from Odactra or from the underlying maternal condition.
Pediatric Use
Approved for use in patients 12 through 65 years of age. Safety and effectiveness in children younger than 12 years of age have not been established.
Geriatric Use
Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Clinical Information
Clinical Pearls
- Odactra is indicated for the treatment of house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in patients 12 through 65 years of age.
- The first dose must be administered in a healthcare setting due to the risk of anaphylaxis.
- Patients must be prescribed and instructed on the use of auto-injectable epinephrine.
- Patients should be advised to avoid taking Odactra if they have any oral inflammation, sores, or wounds, and to wait until the oral cavity has healed.
- Treatment should be continued daily for at least 12 months to achieve optimal benefit, and continued for up to 3 years based on clinical response.
- Patients should be monitored for at least 30 minutes after the first dose for signs of systemic allergic reactions.
Alternative Therapies
- Other sublingual allergen immunotherapies (e.g., Oralair, Grastek, Ragwitek)
- Subcutaneous allergen immunotherapy (allergy shots)
- Symptomatic treatments (e.g., antihistamines, nasal corticosteroids, decongestants, mast cell stabilizers)
- Environmental control measures (e.g., reducing HDM exposure)